Skip to main content

Table 2 Subgroup analyses for the effect of diabetes on risk of colorectal adenoma

From: Type 2 diabetes mellitus and risk of colorectal adenoma: a meta-analysis of observational studies

Subgroup

Sample size

RR (95 % CI)

P value

Heterogeneity

χ 2

I2

P value

Sub-site of adenoma

 Advanced adenoma

2145

1.41 (1.06–1.87)

0.018

1.50

0.0 %

0.473

 Proximal adenoma

9343

1.28 (0.88–1.87)

0.199

10.89

72.4 %

0.012

 Distal adenoma

9343

1.11 (0.89–1.38)

0.353

3.63

17.3 %

0.305

 Colon adenoma

11201

1.06 (0.73–1.53)

0.758

10.72

72.0 %

0.013

 Multiple adenoma

6840

1.95 (0.97–3.94)

0.061

6.73

85.2 %

0.009

Type of diabetes

 Known T2DM

20326

1.56 (1.16–2.08)

0.003

43.88

81.8 %

0.000

 Newly diagnosed T2DM

1604

1.51 (1.16–1.97)

0.002

0.00

0.0 %

0.946

Gender

 Male

7839

1.33 (0.99–1.80)

0.059

4.74

36.7 %

0.192

 Female

5135

1.29 (0.76–2.17)

0.348

10.33

80.6 %

0.006

Area

 Europe

13527

1.27 (1.02–1.57)

0.032

2.18

0.0 %

0.336

 USA

5767

1.69 (1.14–2.51)

0.009

32.18

84.5 %

0.000

 Asia

11684

1.57 (1.21–2.05)

0.001

13.23

62.2 %

0.021

Study type

 Prospective study

13871

1.27 (0.77–2.10)

0.357

11.93

83.2 %

0.003

 Retrospective study

17405

1.57 (1.30–1.89)

0.000

25.40

60.6 %

0.005

 Population based study

6122

1.46 (1.21–1.89)

0.005

2.06

3 %

0.357

Studies with high quality

26046

1.64 (1.26–2.14)

0.000

45.78

78.2 %

0.000

  1. T2DM type 2 diabetes mellitus